The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases
Category: News
Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
The progressive and incurable brain disorder currently affects approximately 100 patients worldwide
PhaSER will provide 8HUM mouse models for the TDI to accelerate a pipeline of novel therapeutic targets
According to the World Health Organization, TB is responsible for over one million annual deaths
The Companion+ Mobile Safety App will be rolled out to a further 115 users within the UK and […]
LDHA and GOT1 enzymes successfully targeted and halted energy production in hard-to-reach cancer cells
Estimated to affect 2.5 million people in the US, synucleinopathies comprise four neurodegenerative disorders
These types of conditions are responsible for 25% of all UK deaths and affect 7.6 million people nationally